Search - tctmd.com

Displaying 941 - 960 of 971

Sort: Relevancy | Date

News Daily News

Increased Clopidogrel Fails to Overcome High Platelet Reactivity

L.A. McKeown

September 20, 2011

News Conference News

ESC Congress 2011: Drugs, Devices Work Together

Caitlin E. Cox

September 06, 2011

News Conference News

Halting Clopidogrel in First Year Following Acute MI Hazardous

September 01, 2011

News Conference News

RUBY-1: Yet Another Novel Anticoagulant Tested in ACS Patients on Antiplatelets

August 31, 2011

News Conference News

Long-term Antiplatelet Therapy: All Risk, No Benefit

August 30, 2011

News Conference News

GRAVITAS Analysis: Lower Cutpoint May Enhance Functional Platelet Testing

August 30, 2011

News Conference News

ASCOT: Unexplained Long-Term Mortality Benefit Found with Atorvastatin

August 29, 2011

News Conference News

Novel Anticoagulants Showing Benefits in A-fib Subgroups

August 29, 2011

News Daily News

Virtual Histology IVUS Links Vulnerable Plaque to Future Events

August 17, 2011

News Daily News

Excess Dyspnea with Ticagrelor Does Not Compromise Mortality Benefit

August 03, 2011

News Daily News

Delayed Primary PCI Generally Superior to Early Fibrinolysis for STEMI

July 25, 2011

News Daily News

Ticagrelor Gains FDA Approval for Use in ACS

Caitlin E. Cox

July 22, 2011

News Daily News

Statin Users Have Better Outcomes After PCI for Stable CAD

L.A. McKeown

July 08, 2011

News Daily News

One-Month Platelet Reactivity After PCI Key Risk Factor for Future Events

June 13, 2011

News Daily News

Predictors of Serious Bleeding in ACS Patients from TRITON-TIMI Identified

June 09, 2011

News Conference News

Different Agents Show Potential as Adjuncts to PCI

Jason Kahn

May 19, 2011

News Conference News

RECLOSE 2-ACS: Poor Responders Show Poor Outcomes Despite Higher Clopidogrel Dose

Caitlin E. Cox

May 18, 2011

News Daily News

High-dose Statins Reduce CIN in ACS Patients Receiving PCI

Jason Kahn

May 05, 2011

News Daily News

Everolimus-Eluting Stents Found Equivalent to First-Generation Stents in Most Patients at 1 Year

Leah Lawrence

April 26, 2011

News Daily News

Elderly STEMI Patients Face Poorer Outcomes After Primary PCI

Caitlin E. Cox

April 20, 2011

Advertisement

Increased Clopidogrel Fails to Overcome High Platelet Reactivity

ESC Congress 2011: Drugs, Devices Work Together

Halting Clopidogrel in First Year Following Acute MI Hazardous

RUBY-1: Yet Another Novel Anticoagulant Tested in ACS Patients on Antiplatelets

Long-term Antiplatelet Therapy: All Risk, No Benefit

GRAVITAS Analysis: Lower Cutpoint May Enhance Functional Platelet Testing

ASCOT: Unexplained Long-Term Mortality Benefit Found with Atorvastatin

Novel Anticoagulants Showing Benefits in A-fib Subgroups

Virtual Histology IVUS Links Vulnerable Plaque to Future Events

Excess Dyspnea with Ticagrelor Does Not Compromise Mortality Benefit

Delayed Primary PCI Generally Superior to Early Fibrinolysis for STEMI

Ticagrelor Gains FDA Approval for Use in ACS

Statin Users Have Better Outcomes After PCI for Stable CAD

One-Month Platelet Reactivity After PCI Key Risk Factor for Future Events

Predictors of Serious Bleeding in ACS Patients from TRITON-TIMI Identified

Different Agents Show Potential as Adjuncts to PCI

RECLOSE 2-ACS: Poor Responders Show Poor Outcomes Despite Higher Clopidogrel Dose

High-dose Statins Reduce CIN in ACS Patients Receiving PCI

Everolimus-Eluting Stents Found Equivalent to First-Generation Stents in Most Patients at 1 Year

Elderly STEMI Patients Face Poorer Outcomes After Primary PCI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content